Answers are grounded in this paper and cite their sources.
OBJECTIVES: Central-line-associated bloodstream infections (CLABSI) significantly contribute to morbidity and mortality in children receiving long-term parenteral nutrition (LT-PN). This study aimed to assess CLABSI incidence rate, risk factors and taurolidine lock therapy (TLT) effectiveness. METHODS: We conducted a 5-year, single-centre prospective cohort study of children on LT-PN. The primary outcome was CLABSI incidence, expressed as episodes per 1000 CL-days (with 95% confidence intervals). RESULTS: Across 27,086 CL-days in 20 children (median age 44 months, interquartile range 88.25), 31 CLABSI episodes occurred, yielding an incidence of 1.14/1000 CL-days (0.80-1.62). Children with enterostomy had a higher incidence (2.24/1000 CL-days [1.33-3.78]) compared with those without (0.80/1000 CL-days [0.50-1.28]; p < 0.05). Subsequent CLABSI episode was more frequent in children with intestinal motility disorders (p = 0.049) and in those receiving total PN without enteral/oral intake (p = 0.049). In multivariable analysis, oral food intake was independently associated with a lower likelihood of CLABSI recurrence (odds ratio [OR] 0.01, 95% CI 0.00-0.68; p = 0.032). Compared with standard care (1.88/1000 CL-days [1.04-3.39]), children on TLT had a lower incidence (1.01/1000 CL-days [0.65-1.56]). CONCLUSIONS: CLABSI incidence in children on LT-PN appears to be influenced by specific risk factors, including enterostomy, intestinal motility disorders, and exclusive PN. TLT was associated with a lower CLABSI incidence. Although statistical significance was not reached these findings suggest a potential benefit of TLT.
No takes yet. Share an insight, caveat, or question.
Scarano et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: